660
Views
25
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Randomized Trial of Zileuton for Treatment of COPD Exacerbations Requiring Hospitalization

, , , , , , , , , , , , , , , , , , , , , , & show all
Pages 21-29 | Published online: 08 Feb 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Timothy E. Albertson, James A. Chenoweth, Skyler J. Pearson & Susan Murin. (2020) The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS). Expert Opinion on Pharmacotherapy 21:2, pages 213-231.
Read now
Sowmya P Lakshmi, Aravind T Reddy & Raju C Reddy. (2017) Emerging pharmaceutical therapies for COPD. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2141-2156.
Read now
Makedonka Gulcev, Cavan Reilly, Timothy J Griffin, Corey D Broeckling, Brian J Sandri, Bruce A Witthuhn, Shane W Hodgson, Prescott G Woodruff & Chris H Wendt. (2016) Tryptophan catabolism in acute exacerbations of chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 2435-2446.
Read now
Jia-Qiang Zhang, Jian-Qing Zhang, Li-Zhou Fang, Ling Liu, Wei-Ping Fu & Lu-Ming Dai. (2015) Effect of oral N-acetylcysteine on COPD patients with microsatellite polymorphism in the heme oxygenase-1 gene promoter. Drug Design, Development and Therapy 9, pages 6379-6387.
Read now
Samuel Louie, Amir A Zeki, Michael Schivo, Andrew L Chan, Ken Y Yoneda, Mark Avdalovic, Brian M Morrissey & Timothy E Albertson. (2013) The asthma–chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations. Expert Review of Clinical Pharmacology 6:2, pages 197-219.
Read now
Hiroo Wada, Shin-ichi Hagiwara, Erika Saitoh, Ryuji Ieki, Yorihiro Yamamoto, Ian M. Adcock & Hajime Goto. (2012) Up-regulation of blood arachidonate (20:4) levels in patients with chronic obstructive pulmonary disease. Biomarkers 17:6, pages 520-523.
Read now

Articles from other publishers (19)

Julia Sieminska, Johan Kolmert, Javier Zurita, Kurt Benkestock, Johanna Revol-Cavalier, Jacek Niklinski, Joanna Reszec, Sven-Erik Dahlén, Michal Ciborowski & Craig E. Wheelock. (2024) A single extraction 96-well method for LC-MS/MS quantification of urinary eicosanoids, steroids and drugs. Prostaglandins & Other Lipid Mediators 170, pages 106789.
Crossref
Rebecca Riedl, Maria Wallert, Stefan Lorkowski & Cornelia Wiegand. (2023) Effects of Histamine and the α-Tocopherol Metabolite α-13′-COOH in an Atopic Dermatitis Full-Thickness Skin Model. Molecules 28:1, pages 440.
Crossref
Sudipto Saha, Sreyashi Majumdar & Parthasarathi BhattacharyyaSudipto Saha, Sreyashi Majumdar & Parthasarathi Bhattacharyya. 2023. Pulmonomics: Omics Approaches for Understanding Pulmonary Diseases. Pulmonomics: Omics Approaches for Understanding Pulmonary Diseases 31 58 .
Alexander G. Mathioudakis, Sachin Ananth, Thomas Bradbury, Balazs Csoma, Pradeesh Sivapalan, Elizabeth Stovold, Gustavo Fernandez-Romero, Zsofia Lazar, Gerard J. Criner, Christine Jenkins, Alberto Papi, Jens-Ulrik Jensen & Jørgen Vestbo. (2021) Assessing Treatment Success or Failure as an Outcome in Randomised Clinical Trials of COPD Exacerbations. A Meta-Epidemiological Study. Biomedicines 9:12, pages 1837.
Crossref
Arindam Chakrabarti, Jordan S. Mar, David F. Choy, Yi Cao, Nisha Rathore, Xiaoying Yang, Gaik W. Tew, Olga Li, Prescott G. Woodruff, Christopher E. Brightling, Michele Grimbaldeston, Stephanie A. Christenson, Mona Bafadhel & Carrie M. Rosenberger. (2021) High serum granulocyte-colony stimulating factor characterises neutrophilic COPD exacerbations associated with dysbiosis. ERJ Open Research 7:3, pages 00836-2020.
Crossref
You Xu, Aneesh Thakur, Yibang Zhang & Camilla Foged. (2021) Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects. Pharmaceutics 13:2, pages 177.
Crossref
Cuixue Wang, Jiedong Zhou, Jinquan Wang, Shujing Li, Atsushi Fukunaga, Junji Yodoi & Hai Tian. (2020) Progress in the mechanism and targeted drug therapy for COPD. Signal Transduction and Targeted Therapy 5:1.
Crossref
Nikhil Gupta, Abhijeet Singh & Rajendra Prasad. (2022) Theophylline and Leukotriene Modifiers: Is There Any Compelling Role in COPD?. Indian Journal of Respiratory Care 9:2, pages 153-161.
Crossref
Claudia C. DoblerAllison S. MorrowBradley BeuschelMagdoleen H. FarahAbdul M. MajzoubMichael E. WilsonBashar HasanMohamed O. SeisaLubna DarazLarry J. ProkopM. Hassan MuradZhen Wang. (2020) Pharmacologic Therapies in Patients With Exacerbation of Chronic Obstructive Pulmonary Disease. Annals of Internal Medicine 172:6, pages 413.
Crossref
Qing-Qing Wu, Wei Deng, Yang Xiao, Jiao-Jiao Chen, Chen Liu, Juan Wang, Yankai Guo, Mingxia Duan, Zhulan Cai, Saiyang Xie, Yuan Yuan & Qizhu Tang. (2019) The 5-Lipoxygenase Inhibitor Zileuton Protects Pressure Overload-Induced Cardiac Remodeling via Activating PPAR α . Oxidative Medicine and Cellular Longevity 2019, pages 1-17.
Crossref
Ernesto Crisafulli, Enric Barbeta, Antonella Ielpo & Antoni Torres. (2018) Management of severe acute exacerbations of COPD: an updated narrative review. Multidisciplinary Respiratory Medicine 13:1.
Crossref
Roberto Benzo, Kristin Vickers, Paul J. Novotny, Sharon Tucker, Johanna Hoult, Pamela Neuenfeldt, John Connett, Kate Lorig & Charlene McEvoy. (2016) Health Coaching and Chronic Obstructive Pulmonary Disease Rehospitalization. A Randomized Study. American Journal of Respiratory and Critical Care Medicine 194:6, pages 672-680.
Crossref
Janice M. Leung, Virginia Chen, Zsuzsanna Hollander, Darlene Dai, Scott J. Tebbutt, Shawn D. Aaron, Kathy L. Vandemheen, Stephen I. Rennard, J. Mark FitzGerald, Prescott G. Woodruff, Stephen C. Lazarus, John E. Connett, Harvey O. Coxson, Bruce Miller, Christoph Borchers, Bruce M. McManus, Raymond T. Ng & Don D. Sin. (2016) COPD Exacerbation Biomarkers Validated Using Multiple Reaction Monitoring Mass Spectrometry. PLOS ONE 11:8, pages e0161129.
Crossref
Jong Hoo Lee, Hyun Jung Kim & Yee Hyung Kim. (2015) The Effectiveness of Anti-leukotriene Agents in Patients with COPD: A Systemic Review and Meta-analysis. Lung 193:4, pages 477-486.
Crossref
Genyo Ikeda, Nobuaki Miyahara, Hikari Koga, Yasuko Fuchimoto, Koichi Waseda, Etsuko Kurimoto, Akihiko Taniguchi, Yasushi Tanimoto, Mikio Kataoka, Mitsune Tanimoto & Arihiko Kanehiro. (2014) Effect of a Cysteinyl Leukotriene Receptor Antagonist on Experimental Emphysema and Asthma Combined with Emphysema. American Journal of Respiratory Cell and Molecular Biology 50:1, pages 18-29.
Crossref
Jacob P. Scott & Marc Peters-Golden. (2013) Antileukotriene Agents for the Treatment of Lung Disease. American Journal of Respiratory and Critical Care Medicine 188:5, pages 538-544.
Crossref
Peter J. Barnes. (2013) New anti-inflammatory targets for chronic obstructive pulmonary disease. Nature Reviews Drug Discovery 12:7, pages 543-559.
Crossref
CHERYL A. GRICE, ANNE M. FOURIE & ALICE LEE-DUTRA. 2012. Anti-Inflammatory Drug Discovery. Anti-Inflammatory Drug Discovery 58 103 .
Asad Tamimi, Dzelal Serdarevic & Nicola A. Hanania. (2012) The effects of cigarette smoke on airway inflammation in asthma and COPD: Therapeutic implications. Respiratory Medicine 106:3, pages 319-328.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.